English
|
中文
HOME
NEWS
EVENTS
Conference
Exhibition
Laws & Regulations
About Us
CAIVD & CPCEM
CAIVD
CPCEM
VIEW
About VIEW
Editorial Board
Contact
Search
News
Home
>
News
In Vitro Diagnostic Industry in China - POCT III
2025-06-10
2. Dry Chemical Technology The biggest difference between “dry chemistry” and traditional “wet chemistry” (i.e., solution chemistry) is the media involved in the chemical reactions. In this method, the liqui..
IVD China last week: Thermo Fisher and Biomobio, Wondfo, Randox and Realbio, BD Medical
2025-06-09
Thermo Fisher and Biomobio Sign Strategic Agreement in Spatial Imaging Thermo Fisher Scientific and Biomobio have successfully concluded a strategic cooperation agreement for the EVOS S1000..
IVD China last week: Fapon and KIVDA, Agilent and MEGAROBO, WeGoBP
2025-05-27
Fapon and KIVDA Sign Strategic Agreement to Deepen China-Korea IVD Collaboration On 23 May, Fapon Biotech signed a strategic cooperation agreement with the Korea In Vitro Diagnostics Associ..
Xi arrives in Hanoi for state visit to Vietnam
2025-04-15
Chinese President Xi Jinping arrived in Hanoi on Monday to pay a state visit to Vietnam.
AdvaMed continues pressure on White House to exempt devices from tariffs
2025-04-09
AdvaMed and nine other healthcare organizations have continued to pressure the White House to exempt medical devices and critical supplies from the Trump administration’s ongoing tariff saga.
Switzerland Global Enterprise Visits CAIVD during CIIE to Foster Sino-Swiss Collaboration in In Vitro Diagnostics
2024-11-15
At the 7th China International Import Expo (CIIE), themed "New Era, Shared Future", representatives from 152 countries, regions, and organizations gathered for national and corporate exhibitions. On 8 November, Switze..
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
2025-08-07
Original from: QIAGEN · Q2 2025 results: Net sales of $534 million (+7% actual rates); adjusted diluted EPS of $0.60 - Net sales +6% CER (constant exchange rates) above outlook for at least +5% C..
Personalis Reports 24 Percent Dip in Q2 Revenues, Cuts Full-Year Sales Guidance
2025-08-07
Personalis reported after the close of the market on Tuesday a 24 percent year-over-year drop in second quarter revenues, missing analyst expectations and prompting the company to slash its full-year sales guidance.
ORASURE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS
2025-08-07
OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended June 30, 2025.
QuidelOrtho Reports Second Quarter 2025 Financial Results
2025-08-07
Original from: QuidelOrtho Second Quarter 2025 Results (all comparisons are to the prior year period) · Total revenue was $614 million, as reported - Non-respiratory revenue was $567 ..
In Vitro Diagnostic Industry in China - POCT XI
2025-08-05
1.5 Gestation Category The most widely used professional and over the counter (OTC) patient self-tests for women’s health are pregnancy and ovulation tests. OTC includes tests offered by pharmacies and other re..
Bio-Rad Reports Second-Quarter 2025 Financial Results
2025-08-05
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the second quarter ended June 30, 2025.
Roche Respiratory Panel Nabs FDA Clearance
2025-08-05
Roche on Monday announced that its Cobas Respiratory 4-flex test for SARS-CoV-2, influenza A/B, and respiratory syncytial virus has received clearance from the US Food and Drug Administration.
IVD China last week: Wantai, Mindray, MedicalSystem, Leadman, AmoyDx
2025-08-04
Wantai Bio’s Wind ESG Rating Soars to AA, Ranking in the Top 7% of Listed Companies in A-Share and Hong Kong Markets Recently, Wantai Bio achieved an upgrade to an AA rating in the presti..
Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search
2025-08-04
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the launch of Test Finderopens in a new tab, a first-of-its-kind generative AI tool developed with Amazon Web Services (AWS). Designed to simplify lab test selection, Test Finder enables healthcare providers to ask questions or describe conditions in plain language and receive curated test recommendations—enhancing the user experience and freeing up more time for patient care.
Total:
3374
Pages:
225
First
Prev
1
2
3
4
..
225
Next
End